Paclitaxel and carboplatin combination chemotherapy has remained the standard of care in the frontline therapy of advanced epithelial ovarian carcinoma during the last decade
Paclitaxel and carboplatin combination chemotherapyhas remained the standard of care in the frontlinetherapy of advanced epithelial ovarian carcinomaduring the last decade